David Ebsworth, president of Bayer Pharmaceutical, the US subsidiary ofthe German group, has said that the company needs to increase its global US market share from 2.2% to 4% and grow significantly thereafter. The company, which has sales of $2.2 billion and employs some 6,500 people, is currently doubling its sales force to over 2,000.
- Meantime, Agfa, a US unit of Bayer, is to sue General Electric Co in an attempt to prevent a former employee from divulging medical-imaging trade secrets to GE, according to the Wall Street Journal. Through its suit in the federal district court in Chicago, Agfa is seeking a temporary restraining order to stop Vishal Wanchoo from using data to benefit GE's medical systems unit. A GE spokesman called the suit "meritless," and said GE is confident it will prevail in court.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze